Article
Michels, S.
ORCID: 0000-0003-3164-870X, Massutí, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A.
ORCID: 0000-0003-3286-1131, Felip, E., Grohé, C., Rodriguez-Abreu, D.
ORCID: 0000-0003-0506-1366, Bischoff, H., Carcereny i Costa, E., Corral, J., Pereira, E., Fassunke, J.
ORCID: 0000-0002-8391-5577, Fischer, R.N.
ORCID: 0009-0001-5271-2160, Insa, A., Koleczko, S., Nogova, L.
ORCID: 0000-0002-4502-1812, Reck, M.
ORCID: 0000-0002-5348-4462, Reutter, T.
ORCID: 0009-0001-5153-7049, Riedel, R.
ORCID: 0000-0002-8883-1188, Schaufler, D., Scheffler, M.
ORCID: 0000-0002-9031-1368, Weisthoff, M.
ORCID: 0000-0001-6536-3898, Provencio, M., Merkelbach-Bruse, S.
ORCID: 0000-0002-0312-5760, Hellmich, M.
ORCID: 0000-0001-5174-928X, Sebastian, M.
ORCID: 0000-0002-0404-7741, Büttner, R.
ORCID: 0000-0001-8806-4786, Persigehl, T.
ORCID: 0000-0001-5928-4405, Rosell, R.
ORCID: 0000-0003-0817-3400 and Wolf, J.
ORCID: 0000-0001-7577-464X
(2024).
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial.
ESMO Open, 9 (2).
pp. 1-10.
Elsevier.
ISSN 2059-7029
Up a level